1 The next adverse reactions transpired in at the very least five% of Depakote-addressed individuals and at an equal or larger incidence for placebo than for Depakote: flu syndrome and pharyngitis. Patients stabilized on rufinamide prior to getting prescribed valproate must begin valproate therap